- Home
- / Argent BioPharma
Argent BioPharma
Stock Price
$0.3
2024-06-03
Market Capitalization
$18.4 M
2024-06-03
Revenue
$181 K
FY, 2025
Argent BioPharma Summary
Company Summary
- Overview
- Argent BioPharma (formerly MGC Pharmaceuticals) is a biopharma company focusing on the cannabinoid (CBD) and medical cannabis business. It supplies GMP (good manufacturing practice) phytocannabinoid derived medicines to patients.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- London, GB | view all locations
- Website
- https://argentbiopharma.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
4 locations detected
London, England HQ
United Kingdom
Eccleston Yards, 25 Eccleston Pl, Belgravia
West Perth, WA
Australia
1202 Hay St
Hlavní město Praha
Czech Republic
6, Ve Smečkách 1258/6
Ljubljana, Ljubljana
Slovenia
Emonska cesta 8
Argent BioPharma Financials
Summary Financials
- Revenue (H1, 2026)
- $171.0K
- Gross profit (H1, 2026)
- $98.0K
- Net income (H1, 2026)
- ($2.9M)
- Cash (H1, 2026)
- $1.5M
- EBIT (H1, 2026)
- ($2.8M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026